NYSE:GOLD
NYSE:GOLDRetail Distributors

Should Gold.com’s (GOLD) High-Profile Rebrand Meaningfully Change How Investors View Its Core Business?

Earlier this month, A-Mark Precious Metals, Inc. officially changed its corporate name to Gold.com, Inc. and, effective December 3, 2025, switched its New York Stock Exchange ticker symbol from AMRK to GOLD, accompanied by bylaw updates to reflect the rebranding. This shift to the highly recognizable Gold.com brand and GOLD ticker may reshape how investors perceive the company’s role in the precious metals market and its future business direction. We’ll now consider how the rebrand to...
NYSE:CHE
NYSE:CHEHealthcare

Chemed (CHE): Evaluating Valuation After This Year’s Double-Digit Share Price Slide

Chemed (CHE) has quietly slid this year, even as its underlying hospice and plumbing businesses keep growing. That disconnect between share price and fundamentals is what makes the stock interesting right now. See our latest analysis for Chemed. The share price has drifted lower this year, with a roughly 20 percent year to date share price decline and a similar double digit drop in one year total shareholder return. This suggests sentiment is fading even as earnings keep grinding higher. If...
NYSE:EOG
NYSE:EOGOil and Gas

Is EOG Resources Mispriced After 2025 Share Price Slide And Strong DCF Upside?

Wondering if EOG Resources at around $109 is a bargain or a value trap right now? You are not alone, and this breakdown will help you see where the market might be mispricing it. The stock has slipped 1.9% over the last week and is still down 12.3% year to date and 11.3% over the past year, even after a strong 164.2% gain over five years, which hints at shifting sentiment around its long term prospects and risk. Recent headlines have focused on EOG tightening its capital discipline,...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Is Henry Schein’s Streamlined Distribution Strategy Creating Value at Around $74 a Share in 2025?

Wondering if Henry Schein at around $74 a share is a quietly undervalued play in healthcare rather than a sleepy distributor? That is exactly what we are going to unpack here. The stock has crept up about 2.1% over the last week and 2.0% over the past month, and is up 8.6% year to date, even though the 1 year return is still slightly negative at around 3.1% and the 3 year return sits near 10.5% in the red. Recent headlines have focused on Henry Schein sharpening its focus on dental and...
NYSE:APAM
NYSE:APAMCapital Markets

Artisan Partners Asset Management (APAM): Valuation Check After November AUM Update and $2.7 Billion Client Redemption

Artisan Partners Asset Management (APAM) just reported preliminary November 2025 assets under management of $180.8 billion, while also disclosing a single $2.7 billion redemption from a non U.S. institutional client tied to local pension dynamics. See our latest analysis for Artisan Partners Asset Management. The stock has been drifting lower in recent months, with a 30 day share price return of minus 7.3 percent and a one year total shareholder return of minus 6.8 percent. This suggests...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

Is Astronics Stock Still Attractive After Its 236.6% Surge Amid Defense Contract Momentum?

Wondering if Astronics is still a smart buy after its huge run, or if you are turning up late to the party? This breakdown is designed to help you decide whether the current price still makes sense. The stock has pulled back slightly over the last week, down 0.2%, but it is still up 13.1% over the past month and an eye catching 236.6% year to date, with a 222.5% gain over the last year and more than 400% over three years. Those kinds of moves usually do not happen in a vacuum. For Astronics,...